Market Intelligence

The COVID-19 vaccine approvals have given health systems (and payers) a glimmer of hope that the surge of acute patient COVID-19 admissions may be ebbing. As we anticipate a sense of normalcy, the shift for payer organizations will likely be toward planning our 2021 healthcare strategies.

Despite so many unknowns, now is the time for providers to take stock of their health system’s financial position and make proactive decisions around setting service rates, negotiating contracts, and mapping potential expansion opportunities. A good first step? Accessing comprehensive data on medical reimbursements.

LexisNexis® MarketView™ shows you who your high-value physicians are, where they spend their time, and how much they are reimbursed. And now, MarketView users not only have access to this information — but the new User Interface brings important insights to life, making complex claims insights accessible while providing users the ability to dig deeper.

Each year, annual flu epidemics occur in the U.S. and around the world. Although the timing, intensity and length varies from one season to another, flu represents a significant public health problem that affects millions of Americans and is associated with hospitalizations and deaths in people of all ages.